Bioventix (LON:BVXP) Shares Fall 2.6% - Should Investors Consider Selling?

Bioventix PLC (LON:BVXP) saw its shares decline by 2.6% during midday trading on Friday. The stock reached a low of GBX 3,450 ($43.54) before closing at GBX 3,456 ($43.62). A total of approximately 7,664 shares were traded, which is a significant increase of 31% compared to the average daily volume of 5,833 shares. The previous close for the stock was GBX 3,550 ($44.81).

Performance Overview of Bioventix Stock

Bioventix currently boasts a market capitalization of £180.40 million, along with a price-to-earnings ratio of 2,120.25 and a beta figure of 0.35. The company's fifty-day moving average price stands at GBX 3,712.29, while the 200-day moving average is at GBX 4,034.04.

Recent Dividend Announcement

Recently, Bioventix declared a dividend to its shareholders, which was disbursed on Thursday, November 21st. Shareholders who held shares as of Thursday, November 7th received a dividend of GBX 87 ($1.10) per share. The ex-dividend date fell on November 7th as well. This dividend represents a positive increase from Bioventix's prior payout of $68.00, yielding approximately 2.4%. However, it's important to note that the company's dividend payout ratio is exceptionally high at 9,693.25%.

Insider Trading Activity

In related news, insider Bruce Hiscock purchased 24 shares of Bioventix on Friday, November 22nd. The transaction was completed at an average price of GBX 3,822 ($48.24) per share, totaling £917.28 ($1,157.74). Corporate insiders currently own 8.02% of Bioventix's stock.

About Bioventix

Bioventix PLC specializes in the creation, manufacture, and supply of sheep monoclonal antibodies (SMAs) utilized for diagnostic purposes globally. The company's offerings include a range of purified SMAs targeting thyroid needs, vitamin D levels, cardiac health, drug abuse detection, fertility issues, oncology, and other miscellaneous health indications. Additionally, they provide a Pyrene (HOP-G) ELISA kit designed to monitor human exposure to industrial pollutants.

Should You Invest in Bioventix?

As of now, analysts have a "Hold" rating on Bioventix shares. However, top-rated analysts have recommended five other stocks that they believe present better investment opportunities at the moment. It may be worthwhile for investors to consider these alternatives before making any decisions about Bioventix.

Bioventix, stocks, dividend